Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus rosuvastatin for inflammatory markers in acute coronary syndrome
IRCT20190903044682N1Phase 3Completed
- Sponsor
- Neyshabour University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Atorvastatin arm with Rosuvastatin arm (2 arms). Primary endpoints: Apolipoprotein A, Apolipoprotein B and 8 more. Started Sep 2019; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on IRCT20190903044682N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190903044682N1.